soul trial oral semaglutide cardiovascular outcomes 2024 nejm results Presented at #ERA24: FLOW trial: In patients with type 2 diabetes and chronic kidney disease, weekly significantly reduced risks of major kidney events, events, and death from any cause while Semaglutide cardiovascular outcomes align more
Description
10.21037/tcr-20-3462 [DOI] [PMC free article] [PubMed] [Google Scholar] Hong J.-H., Kim D.-H., Lee M.-K
However, selecting between them depends on a few factors, such as patient condition and overall health
The DTSQc used the same eight items, but participants rated their change in treatment satisfaction with semaglutide versus before initiating oral semaglutide, on a scale of 3 (much less satisfied now) to + 3 (much more satisfied now)
Maintaining good hydration is important for overall health and well-being
Most often, patients restart their medication 1 to 2 weeks post-operative, once they've regained normal oral intake and clearance from their surgeon
American thyroid association statement on postoperative hypoparathyroidism: diagnosis, prevention, and management in adults
